Cytoki Pharma
PrivateLast Round
Series A
May 4, 2021
Total Funding Raised
$47.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cytoki Pharma operates in Healthcare & Life Sciences and is based in Denmark. Its latest recorded funding round was a Series A round in May 2021.
Cytoki Pharma is a biotechnology company that develops lipidated Interleukin-22 (IL-22) therapeutics to treat metabolic diseases and conditions involving epithelial injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytoki Pharma Comparables
Compare Cytoki Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alveus Therapeutics | 82% | |
| Antag Therapeutics | 78% | |
| Synthekine | 76% |
For institutional investors. Book with your work email.
Cytoki Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 4, 2021 | ||||
| Seed | Jul 1, 2019 |
For institutional investors. Book with your work email.
Cytoki Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeckfonden BioCapital | Series A |
| Ysios Capital | Series A |
| +ND Capital | Series A |
| Seventure Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 402% MoM.
- May 4, 2021
$45M round led by Lundbeckfonden BioCapital.
For institutional investors. Book with your work email.
Cytoki Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytoki Pharma's valuation, stock price, and market status.
Is Cytoki Pharma a public or private company?
Cytoki Pharma is a private company.
What is the current stock price of Cytoki Pharma?
Cytoki Pharma is a private company, so its shares have no public market price. Caplight tracks Cytoki Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytoki Pharma worth (valuation)?
Valuation information for Cytoki Pharma is not publicly available.
Can I buy Cytoki Pharma stock?
Cytoki Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytoki Pharma's last funding round?
Cytoki Pharma's most recent funding round was Series A on May 4, 2021.
Who are the main investors in Cytoki Pharma?
Key investors in Cytoki Pharma include Lundbeckfonden BioCapital.
Will Cytoki Pharma IPO soon?
No public IPO plans have been announced for Cytoki Pharma.
How can I track Cytoki Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Cytoki Pharma's shares on secondary markets.